Effects of a combination treatment of KD5040 and L-dopa in a mouse model of Parkinson's disease
Abstract Background Although the dopamine precursor L-3, 4-dihydroxyphenylalanine ( l -dopa) remains the gold standard pharmacological therapy for patients with Parkinson's disease (PD), long-term treatment with this drug has been known to result in several adverse effects, including l -dopa-in...
Saved in:
Main Authors: | Sora Ahn (Author), Taek-Jin Song (Author), Seong-Uk Park (Author), Songhee Jeon (Author), Jongpil Kim (Author), Joo-Young Oh (Author), Jaehwan Jang (Author), Sanhwa Hong (Author), Min-A Song (Author), Hye-Seoung Shin (Author), Young-Rim Jung (Author), Hi-Joon Park (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2017-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assesment of the effects of L-Dopa on Parkinson's Disease
by: J. Wright
Published: (1971) -
Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA
by: Ting Ting Zhao, et al.
Published: (2017) -
NANOENKAPSULASI L-DOPA DALAM PATI NANOPARTIKEL UNTUK KANDIDAT OBAT ANTI PARKINSON
by: Dhea Salsabila, -
Published: (2022) -
l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson's Disease
by: Yoshio Goshima, et al.
Published: (2019) -
Non-dopaminergic Alterations in Depression-Like FSL Rats in Experimental Parkinsonism and L-DOPA Responses
by: Nicoletta Schintu, et al.
Published: (2020)